Steff Ascough
@steffascough.bsky.social
Immunologist interested in the adaptive immune response to pathogens & vaccine development. Prodigious coffee drinker
Reposted by Steff Ascough
Would you get sick for science? 😷
That's the question we're putting to the public.
What is a human challenge study? We're explaining all this and more tonight!
If you happen to be in South Kensington, London, drop on by Imperial College London and visit us at #ImperialLates! 🧪
That's the question we're putting to the public.
What is a human challenge study? We're explaining all this and more tonight!
If you happen to be in South Kensington, London, drop on by Imperial College London and visit us at #ImperialLates! 🧪
January 29, 2026 at 6:20 PM
Would you get sick for science? 😷
That's the question we're putting to the public.
What is a human challenge study? We're explaining all this and more tonight!
If you happen to be in South Kensington, London, drop on by Imperial College London and visit us at #ImperialLates! 🧪
That's the question we're putting to the public.
What is a human challenge study? We're explaining all this and more tonight!
If you happen to be in South Kensington, London, drop on by Imperial College London and visit us at #ImperialLates! 🧪
Reposted by Steff Ascough
A brilliant day at our 'Diversity in immunology' event with @london-immuno.bsky.social 🧬
We explored the many layers of diversity, from immune responses to researcher perspectives, through inspiring talks, posters, and conversations #LIG25
Don’t miss future events: https://bit.ly/3v2aAi1
We explored the many layers of diversity, from immune responses to researcher perspectives, through inspiring talks, posters, and conversations #LIG25
Don’t miss future events: https://bit.ly/3v2aAi1
July 11, 2025 at 3:00 PM
A brilliant day at our 'Diversity in immunology' event with @london-immuno.bsky.social 🧬
We explored the many layers of diversity, from immune responses to researcher perspectives, through inspiring talks, posters, and conversations #LIG25
Don’t miss future events: https://bit.ly/3v2aAi1
We explored the many layers of diversity, from immune responses to researcher perspectives, through inspiring talks, posters, and conversations #LIG25
Don’t miss future events: https://bit.ly/3v2aAi1
Preprint of some fantastic, disruptive RSV CHIM research from our colleagues in Utrecht www.researchsquare.com/article/rs-5... Really showing the utility of experimental human challenges in drug discovery.
Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trial
Intramuscular monoclonal antibodies (mAbs) can prevent respiratory infections but are costly and not globally available. The development of intranasal mAbs offers a promising cost-reducing and non-inv...
www.researchsquare.com
January 27, 2025 at 10:00 AM
Preprint of some fantastic, disruptive RSV CHIM research from our colleagues in Utrecht www.researchsquare.com/article/rs-5... Really showing the utility of experimental human challenges in drug discovery.
Never had 2 papers published on the same day
February 13, 2024 at 5:05 AM
Never had 2 papers published on the same day